Company Filing History:

21 out of 220

Pharmacia Corporation

patents

12 out of 1,323

G.d. Searle & Company

Pharmacia Corporation Global Patent Department

patent

Years Active: 2002-2010

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7700658 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2010-04-20),

2. 7253211 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2007-08-07),

3. 7122536 - (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity (2006-10-17),

4. 7119203 - Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors (2006-10-10),

5. 6909001 - Method of making tricyclic aminocyanopyridine compounds (2005-06-21),

6. 6803388 - (R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-10-12),

7. 6765023 - Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-07-20),

8. 6750233 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),

9. 6750228 - Aromatic sulfone hydroxamic acid metalloprotease inhibitor (2004-06-15),

10. 6723753 - Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

11. 6723752 - (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-04-20),

12. 6710089 - Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-23),

13. 6699898 - Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-03-02),

14. 6696472 - Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

15. 6696435 - Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity (2004-02-24),

Title: The Legacy of William F. Vernier, an Inventor from St. Louis

Introduction: William F. Vernier, a distinguished inventor hailing from St. Louis, Missouri, has made significant contributions to the world of innovation through his groundbreaking work in various fields.

Latest Patents: William F. Vernier's latest patents include cutting-edge technologies in the automotive industry, particularly focusing on advancements in electric vehicle components and safety features.

Career Highlights: Throughout his illustrious career, William F. Vernier has been recognized for his pioneering spirit and inventive mindset, leading to the development of revolutionary solutions that have reshaped industries.

Collaborations: William F. Vernier has collaborated with leading research institutions and automotive companies to bring his visionary ideas to life, fostering a culture of innovation and progress in the field.

Conclusion: William F. Vernier's dedication to pushing the boundaries of what is possible through his inventions has solidified his reputation as a trailblazer in the world of innovation, leaving a lasting impact for generations to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

For the Inventor, By the Inventor

William F Vernier

Location History:

Company Filing History:

Years Active: 2002-2010